News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
492,733 Results
Type
Article (36631)
Company Profile (321)
Press Release (455781)
Section
Business (142014)
Career Advice (1386)
Deals (27579)
Drug Delivery (103)
Drug Development (72983)
Employer Resources (114)
FDA (11518)
Job Trends (10461)
News (258276)
Policy (27750)
Tag
Academia (2119)
Alliances (45645)
Alzheimer's disease (1281)
Approvals (11492)
Artificial intelligence (167)
Bankruptcy (260)
Best Places to Work (8795)
Biotechnology (252)
Breast cancer (199)
Cancer (1611)
Cardiovascular disease (128)
Career advice (1161)
CAR-T (126)
Cell therapy (352)
Clinical research (58407)
Collaboration (664)
Compensation (344)
COVID-19 (2555)
C-suite (145)
Data (1540)
Diabetes (213)
Diagnostics (4060)
Earnings (50796)
Events (70625)
Executive appointments (450)
FDA (12333)
Funding (548)
Gene therapy (256)
GLP-1 (687)
Government (4214)
Healthcare (13654)
Infectious disease (2678)
Inflammatory bowel disease (117)
Interviews (239)
IPO (12671)
Job creations (2103)
Job search strategy (1005)
Layoffs (353)
Legal (7266)
Lung cancer (233)
Manufacturing (211)
Medical device (7252)
Medtech (7254)
Mergers & acquisitions (15263)
Metabolic disorders (581)
Neuroscience (1699)
NextGen: Class of 2025 (4514)
Non-profit (3107)
Northern California (1834)
Obesity (325)
Opinion (208)
Parkinson's disease (110)
Patents (154)
People (38099)
Phase I (18579)
Phase II (25882)
Phase III (19200)
Pipeline (737)
Postmarket research (2034)
Preclinical (7883)
Radiopharmaceuticals (250)
Rare diseases (331)
Real estate (3262)
Regulatory (17990)
Research institute (1910)
Resumes & cover letters (205)
Southern California (1564)
Startups (2726)
United States (15317)
Vaccines (682)
Weight loss (242)
Date
Today (62)
Last 7 days (674)
Last 30 days (2243)
Last 365 days (28934)
2025 (4464)
2024 (29547)
2023 (32866)
2022 (42104)
2021 (45098)
2020 (41714)
2019 (33750)
2018 (25326)
2017 (24806)
2016 (23021)
2015 (26825)
2014 (20473)
2013 (16335)
2012 (17008)
2011 (17646)
2010 (16406)
Location
Africa (604)
Arizona (115)
Asia (30726)
Australia (5455)
California (4140)
Canada (1409)
China (369)
Colorado (168)
Connecticut (191)
Europe (72034)
Florida (562)
Georgia (142)
Illinois (332)
Indiana (196)
Japan (109)
Maryland (691)
Massachusetts (3210)
Michigan (119)
Minnesota (198)
New Jersey (1183)
New York (1189)
North Carolina (654)
Northern California (1834)
Ohio (131)
Pennsylvania (840)
South America (844)
Southern California (1564)
Texas (529)
Washington State (373)
492,733 Results for "affimed therapeutics ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Affimed Reports Third Quarter 2024 Financial Results & Business Update
November 15, 2024
·
13 min read
Business
Affimed Reports First Quarter 2024 Financial Results & Business Update
Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported financial results and provided an update on clinical and corporate progress for the quarter ended March 31, 2024.
June 12, 2024
·
15 min read
Affimed Announces Annual General Meeting of Shareholders - May 28, 2024
Affimed N.V. announced that its 2024 Annual General Meeting of Shareholders will be held on June 26, 2024 at 09:00 a.m. CET at the offices of De Brauw Blackstone Westbroek N.V., Burgerweeshuispad 201, 1076 GR Amsterdam, the Netherlands.
May 28, 2024
·
1 min read
Drug Development
Affimed Reports 2023 Financial Results and Operational Progress
Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported financial results and provided an update on clinical and corporate progress for the year ended December 31, 2023.
March 28, 2024
·
15 min read
Business
Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024
Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that it will release first quarter 2024 results and corporate update on Wednesday, June 12, 2024.
June 5, 2024
·
1 min read
Press Releases
Affimed Appoints Shawn M. Leland as Chief Executive Officer
September 3, 2024
·
4 min read
Press Releases
Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)
December 18, 2024
·
9 min read
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
Press Releases
Alcresta Therapeutics Announces FDA Expanded Use Clearance for RELiZORB® (iMMOBILIZED LIPASE) Cartridge for Pediatric Patients 1 Year of Age and Older
January 16, 2025
·
3 min read
Press Releases
Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
December 9, 2024
·
5 min read
1 of 49,274
Next
